Immunophotonics raises additional $600,000 for clinical trials

Immunophotonics, a St. Louis startup developing a cancer vaccine to treat metastatic cancer with immunotherapy, added $600,000 to its Series A funding round, bringing the total value of the round to $2.48 million.

The company plans to use the funds for human clinical trials in Latin America and to file for trials in the U.S.

Participants in the funding round include Cultivation Capital, St. Louis Arch Angels, Billiken Angels and the Missouri Technology Corporation.

Read more from the St. Louis Business Journal


Tags:, , , , ,

Leave a Reply